NoI_FDA_1169135.doc

PRESOLICITATION NOTICE: INTENT TO AWARD A SOLE-SOURCE CONTRACT

INTENDED SOURCE: Ohio State University 281 W. Lane Ave. | Columbus, Ohio 43210 ANTICIPATED PERIOD of PERFORMANCE: September 30, 2016 – September 29, 2017

DESCRIPTION OF REQUIREMENT:

Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, the U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) intends to award a sole source contract to Ohio State University of Wooster, OH for services to support Office of Applied Research and Safety Assessment (OARSA) consortium. The anticipated period of performance of the contract will be 1 year for services.

The applicable North American Industry Classification System (NAICS) code for this acquisition is 541690 "Other Scientific and Technical Consulting Services.”

FDA has a need to only acquire services to support the Office of Applied Research and Safety Assessment Consortium. These services will provide environmental sampling studies and sampling sequences for analysis for OARSA. These sequences will be uploaded into CFSAN’s GenomeTracker. They will also provide a framework on-going on farm samples for both genomic and metagenomics methods and research for OARSA. In addition, they will provide a framework for identified data gap research for OAO and for OFS.

The Government intends to solicit and negotiate directly with Ohio State University and no solicitation will be issued. This notice of intent is not a request for competitive proposals or quotations; however, if any interested party believes they can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities must be submitted in writing and must contain material in sufficient detail to allow the government to determine if the party can perform the requirement. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. All interested parties must express their interest and capabilities in writing via email to Robert.Maydwell@fda.hhs.gov within fifteen (15) days after the date of publication of this notice. No faxed documents will be accepted. If no responsive statements are received within fifteen (15) days, an award will subsequently be made to Ohio State University.

This is a Federal contract opportunity; FDA-NOI-1169135 for services at Food and Drug Administration Office of Acquisitions and Grants Services - Rockville, MD. Response Due NLT 2:30 PM EST August 17, 2016.

Due

08/17/16

Solicitation Number

FDA-NOI-1169135

Set-Aside

No Set-Aside Used

Contact(s)

Robert Maydwell Category

Services to Support OARSA Consortium Agency

Department of Health and Human Services

Office

Food and Drug Administration

Location

Office of Acquisitions and Grants Services - Rockville